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patients
Abstract
BACKGROUND: Symptomatic patients harboring a brainstem cavernoma are treated surgically with
increasing frequency. Generally, the patient's benefit from this difficult surgical intervention is
quantified by the assessment of neurological symptoms.
OBJECTIVE: To document the beneficial effect of surgery in a larger patient population by assessing
the postoperative quality of life (QoL).
METHODS: In a series of 71 surgically treated patients, a detailed neurological status was assessed by
Patzold Rating and Karnofsky Performance Status Scale (KPS). Patients rated their QoL with the SF-36
questionnaire. To document the effect of surgery on QoL, we devised a supplementary questionnaire.
The last 24 patients completed SF-36 pre- and postoperatively.
RESULTS: KPS improved in 44 of 71 surgical patients (62%), remained unchanged in 19 (27%) and
deteriorated in 8 (11%) individuals. Patzold Rating showed a more detailed picture of the neurological
symptoms. It correlated significantly with KPS, which underlines its usefulness for patients with
brainstem lesions. In the SF-36 score the Mental Component Summary (MCS) improved with surgery
(paired test, p = 0.015). In addition, 58 individuals (82%) declared a clear subjective benefit of surgery.
CONCLUSION: The results of this large series support the notion that microsurgical removal of a
brainstem cavernoma represents an effective therapy in experienced hands, and is generally associated
with good clinical outcome, both neurologically and in terms of QoL.
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ABSTRACT 
Background: Symptomatic patients harboring a brainstem cavernoma are 
treated surgically with increasing frequency.  Generally, the patient’s benefit from this 
difficult surgical intervention is quantified by the assessment of neurological 
symptoms.  
Objective: For the first time, this study aims to document the beneficial effect 
of surgery in a larger patient population by assessing the postoperative quality of life 
(QoL). 
Methods: In a series of 71 surgically treated patients, a detailed neurological 
status was assessed by Patzold Rating and Karnofsky Performance Status Scale 
(KPS). Patients rated their QoL with the SF-36 questionnaire. To document the effect 
of surgery on QoL, we devised a supplementary questionnaire. The last 24 patients 
completed SF-36 pre- and postoperatively. 
Results: KPS improved in 44 out of 71 surgical patients (62%), remained 
unchanged in 19 (27%) and deteriorated in 8 (11%) individuals. Patzold Rating 
showed a more detailed picture of the neurological symptoms. It correlated 
significantly with KPS, which underlines its usefulness for patients with brainstem 
lesions. In the SF-36 score the Mental Component Summary (MCS) improved with 
surgery (paired test, p = 0.015). In addition, 58 individuals (82%) declared a clear 
subjective benefit of surgery. 
Conclusion: The results of this quite large series support the notion that 
microsurgical removal of a brainstem cavernoma represents an effective therapy in 
experienced hands, and is generally associated with good clinical outcome, both 
neurologically and in terms of QoL. 
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INTRODUCTION 
Cavernous malformations are found in 0.4-0.8% of the population.1-6 They 
represent 8-20% of all vascular malformations. Their hemorrhage rate may reach 6% 
per patient year6-7. About 10-35% of cavernomas arise in the brainstem.6, 8-9. These 
hamartous vascular anomalies are characterized by densely packed, grossly 
enlarged immature capillaries without intervening neural tissue. Macroscopically they 
appear as mulberry-like heterogeneous masses. In T2-weighted MRI, hyperintense 
zones and partial contrast enhancement may be seen. With the advent of the MRI 
era, the detection rate of deep-seated cavernomas has rapidly increased.  
Due to the high density of cranial nerve nuclei and fiber tracts within the 
brainstem, severe neurological symptoms may be caused even by small 
hemorrhages, but may also evolve as morbidity following surgical treatment. While 
some authors suggest a conservative management 4, 10-11 or radiosurgery,12-13 
microsurgical extirpation of brainstem cavernomas has increasingly been applied to 
treat symptomatic patients.1-2, 14-23 
The goal of surgical treatment is not only the improvement of neurological 
symptoms, but also preservation of the patient’s quality of life (QoL). Only few 
authors mention the necessity of relevant disease-specific outcome parameters to 
guide clinical decisions and further research.24-27 A systematic assessment of 
postoperative QoL in patients who underwent microsurgical resection of a brainstem 
cavernoma has not yet been undertaken, particularly in a large patient series. With 
the present analysis of 71 patients operated on for brainstem cavernoma, we intend 
to underline the role of QoL when assessing the outcome of such a difficult surgical 
intervention. 
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MATERIALS AND METHODS 
Patient groups 
In this study we included all patients harboring a brainstem cavernous 
malformation that underwent direct surgical resection of the lesion between 1996 and 
2007. All surgical procedures were performed by the senior author (H. B.). Patients 
with postoperative follow-up less than 6 months at the end of data acquisition 
(02/2007) were excluded. The end of data acquisition was due to the senior author’s 
move from Marburg to Zurich. One male patient succumbed to hepatitis about 4 
months after surgery. Two further patients were lost to follow up despite extensive 
search. For this reason the patient series has not been labeled “consecutive”. While a 
total of 100 patients were operated on in the time period, the selection criteria lead to 
a series of 71 patients in the current study. 
The last 24 consecutive patients of this series filed a questionnaire both pre- 
and postoperatively; we refer to this subgroup as the “prospective subgroup”. The 
remaining 47 patients form the “retrospective subgroup”. 
 
Cavernoma location and previous hemorrhages 
Cavernoma location was classified into one of the three anatomical categories 
midbrain, pons, and medulla oblongata (Table 1). 
The criteria to define a previous hemorrhage episode were: 
1) Acute onset of neurological deficit lasting over 24 hours;  
2) Deterioration of pre-existing symptoms or manifestation of new symptoms and, 
accordingly,  
3) Corresponding findings in neuroimaging.  
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All available clinical records and radiographs, especially the most sensitive 
MR-images, were reviewed and analyzed. A detailed description of patient selection 
criteria and surgical technique has been provided earlier.1  
 
Neurological status 
The preoperative and postoperative neurological status of all patients was 
classified by doctors using the Karnofsky Performance Status Scale (KPS). In the 
KPS scores range from 0 (dead) to 100 (no evidence of disease). For more extensive 
classification, we used the Neurological Rating of Patzold (PR).28 It tests cranial 
nerves, motility, motor disturbances, pathological reflexes, sensory deficit, gait 
disturbances, and psychological symptoms to achieve a grading of functional 
disturbances. PR scores represent a weighted sum of clinical symptoms. The rating 
was applied on the day before surgery and on follow-up examination that took place 
at least 6 months after resection. In the retrospective group of patients, preoperative 
PR was established from patient records. 
 
Quality of Life (QoL) 
All patients assessed their QoL at last follow-up using the non-disease-specific 
questionnaire Short Form 36 health survey (SF-36).29 In the SF-36, scores range 
from 0 (worst score) to 100 (best score). The SF-36 scores comprise the following 8 
health concepts: physical functioning (PF), role physical (RP), role emotional (RE), 
social functioning (SF), mental health (MH), bodily pain (BP), vitality (VT), and 
general health (GH). The scores VT, SF, RE, MH are then transformed to the mental 
component summary (MCS)  and scores PF, RP, BP GH to the physical component 
summary (PCS) (www.SF-36.org)30.  
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In addition, patients of the “prospective subgroup” completed the SF-36 also 
before surgery. Because of the relatively small number of patients in the “prospective 
subgroup”, we restrict our longitudinal analysis to PCS and MCS.  
As a supplement to SF-36 we developed a questionnaire to assess the QoL 
especially after surgical treatment. The questions of this supplementary questionnaire 
were: 1) Would you rate your state of health after surgery better than before? 2) Do 
you feel relief after surgery? 3) Do you regret your decision for surgical removal? 4) 
Would you recommend the surgical procedure you have experienced to a close 
person? All patients completed the SF-36 and the supplement at last follow-up.  
 
Data analysis and statistics 
Data was analyzed using Microsoft Excel (office.microsoft.com), SPSS 
Statistics 18 (www.spss.com), and Matlab 2009b (www.mathworks.com). For 
statistical comparison between groups, the non-parametric Wilcoxon test was applied 
whenever applicable. For correlations we used non-parametric Spearman correlation. 
 
RESULTS 
Patient characteristics     
There were 33 females and 38 males (54%) in this series (Table 1). Age 
ranged from 13 to 69 years (mean 40 y, median 36 y). Seventy out of 71 patients 
were symptomatic before surgery, having experienced at least one bleeding episode 
before treatment. Out of all brainstem lesions, 44 (62%) were detected in the pons, 
18 (25%) in the midbrain, and 9 (13%) within the medulla. Three patients harbored a 
single brainstem cavernoma in combination with multiple cavernous malformations 
elsewhere in the central nervous system. In 2 patients there were 3 and, respectively, 
4 lesions in the brainstem. With one exception, all patients were symptomatic from 
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one or more hemorrhages. One patient had undergone craniotomy for a resection of 
a medulloblastoma with consecutive radiation 10 years previously prior to the 
brainstem cavernoma resection. None of the patients were treated preoperatively 
with radiation or stereotactic radiosurgery. 
The prospective subgroup consisted of 9 females and 15 males (63%), age 
ranged from 13 to 69 y (median 33.5 y). History, clinical findings, distribution of sex, 
location within the brainstem and age did not differ significantly from the 
characteristics of the remaining patients (Table 1). 
 
Preoperative hemorrhages 
After surgery, we analyzed patient records for preoperative hemorrhages.  We 
found evidence of preoperative hemorrhages in 70 patients. In one patient without 
clinical evidence of a hemorrhage, the cavernous malformation was detected at the 
occasion of an MRI-control due to a previously surgically treated left frontal 
cavernous malformation.  
 
Radicality of resection and cavernoma reappearance 
For the postoperative development, we analyzed MR-images obtained at each 
follow-up session starting from 6 months after resection. In 69 patients we found no 
lesion remnant and no signs for re-hemorrhage or micro-hemorrhage of the resected 
lesions. This is evidence for an in toto resection of the cavernoma in these patients. 
We detected de novo lesions in several patients, however, not within their 
brainstems.  
In 23% of patients an associated venous malformation was detected on 
preoperative MRI. In each case the venous malformation was spared during surgery 
and remained visible on postoperative MRI. 
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Reappearance of a cavernoma in the resection cavity was detected on MR-
images of two patients. One female patient (age at first surgery 13y) experienced a 
symptomatic episode after one year. Due to lesion growth and progressive symptoms 
this patient underwent a second procedure 2 years after the first one with complete 
cavernoma removal. In the other patient (f, age at surgery 63y) a symptomatic 
cavernoma was detected after 4 years. Similar to the previous patient, she underwent 
a second procedure with total resection. Both individuals did well after the second 
surgery. 
 
Neurological Outcome 
Out of all 71 patients, 17 (24%) were free of neurological deficits 
postoperatively. None of the patients died as a result of surgery. Follow-up ranged 
from 6 to 100 months, median 17 months. Median KPS was 70% preoperatively and 
80% postoperatively. KPS improved in 44 (62%) out of 71 patients, remained 
unchanged in 19 (27%), and deteriorated in 8 (11%) individuals. KPS improvement is 
statistically significant with p < 10-6 (Wilcoxon signed rank test). The change of KPS 
scores due to surgery is illustrated in Fig. 1 for all patients individually. 
Median PR was 7 preoperatively and 2 postoperatively. PR improved in 51 out 
of 71 patients (72%), remained unchanged in 11 (15%) and in 9 patients (13%) the 
neurological state was worse after surgical treatment. PR improvement over the 
entire group is statistically significant with p < 10-6 (Wilcoxon signed rank test). 
We also compared the PR and KPS schemes. An increase in KPS correlated 
with a decrease in PR in the same patient with ρ = -0.49, p < 10-4 (Figure 2). Thus 
both ratings gave a similar description of the effect of surgery. 
Neurological rating was also sensitive to the number of preoperative bleeding 
episodes and the localization of the cavernoma. In patients with pontine and 
 9
H. Bertalanffy 
medullary cavernomas, postoperative PR showed less deficits (ρ = 0.3 p < 0.01) than 
in patients with midbrain lesions. Both pre- and postoperative scores correlated with 
the number of bleeding episodes (KPS ρ = -0.3 p < 0.02; PR ρ = 0.3 p < 0.01), 
indicating a worse neurological state for those patients with more bleeding episodes. 
In addition, PR improvement was more remarkable in patients with more bleeding 
episodes (ρ = 0.4 p < 0.001); obviously, these patients had a higher benefit from 
surgery.  
 
Effect of surgery on QoL 
Of all 71 individuals, 62 patients (87%) pursued the same professional activity 
as before surgery at last follow-up. The postoperative time interval to last follow-up 
did not correlate with any of the scores KPS, PR or SF-36 within our range of 6 - 100 
months. For the first 4-6 postoperative months we have anecdotal reports that most 
patients suffered from lack of concentration and reduced stress-resistance. These 
deficits turned out to be only transient and were not present at last follow up.  
For our prospective subgroup of patients with both preoperative and 
postoperative SF-36 assessment, QoL of patients was documented with a median 
follow-up of 11.5 months, range 6-30 months. For the mental component summary 
(MCS), median MCS was 40 preoperatively and 49 postoperatively. MCS improved in 
13 out of 24 patients (54%), remained within a range of 5 points in 9 (38%) and 
deteriorated in 2 (8%) (Fig. 3). MCS improvement in individual patients is statistically 
significant with p = 0.016 (Wilcoxon paired signrank test). PR decrease and 
postoperative MCS were correlated with ρ = -0.59 (p = 0.002), which underlines the 
effect of reduced neurological symptoms for good QoL assessment also on the 
subjective level. 
 10
H. Bertalanffy 
The particular effects of surgical treatment on QoL were assessed in detail by 
our supplementary questionnaire. Of all 71 patients, 58 (82%) felt good or better after 
surgery. Out of these 58 patients, 16 (23%) felt much better, 21 (29%) very good and 
21 (29%) responded to feel good after surgery. Patients responded more positively to 
this question with increasing age (ρ = 0.3, p = 0.003), if they had more neurological 
deficits pre- or postoperatively (PR ρ = 0.5, p < 0.001), and if they performed well 
postoperatively (KPS ρ = -0.6, p<0.001) or had improved due to surgery (KPS 
change ρ = -0.5, p<0.001). Of all 71 patients, 63 (89%) stated to have experienced 
emotional relief, while 4 (6%) others did not or were unsure, respectively. Only 2 
patients (3%) regretted their decision of having undergone surgery, while 64 
individuals (90%) did explicitly not regret this decision. Five patients did not specify. 
When asked whether they would recommend surgery to a close person in the same 
situation, none of the patients would advise against surgery, while 59 patients (83%) 
would actively recommend surgery.  
There was a discrepancy between subjective scores and doctor’s neurological 
assessment in 8 of 71 patients (11%). Four patients rated their state of health worse 
than before surgery even though objectively, a neurological improvement was 
indicated by KPS and PR. Conversely, 4 patients with a slight deterioration in KPS 
and PR declared improvement in state of health by surgery. 
 
Case presentation  
A woman (36 y, f) presented with left-sided hemi-hypoesthesia, sensory 
deficits in trigeminal area on both sides and gait disturbances after at least two 
bleedings (KPS 80%, PR 10 points). Preoperative imaging (Figure 4 AB) revealed a 
particularly large intraaxial lesion with significant distortions of the long fiber tracts. 
After extirpation, no residual cavernoma could be detected at last follow-up (Fig. 4 C), 
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and the shifted fiber tracts have returned almost completely to their natural position 
(Fig. 4 D). Neurologically, the patient showed a discrete hypesthesia in the trigeminal 
area on the left side and a slight left-sided hemisensory loss. KPS remained 
unchanged, PR improved to 6 points. On SF-36, the physical component summary 
PCS improved from 27 to 49. In comparison with before surgery, the patient rated her 
health after surgery as “very good”. 
 
DISCUSSION 
While a number of recent publications related to brain stem cavernoma 
treatment have dealt with postoperative outcome,11, 16, 20, 22-23, 31 there is no generally 
accepted standard evaluation of the outcome after microsurgical resection of 
brainstem cavernomas. Moreover, only few authors have presented patient studies 
relating to QoL after neurosurgical interventions. 24-27  
 
Objective Neurological Rating 
To compare the neurological state of each individual before and after surgical 
treatment, we applied the PR, which accounts for the complete set of possible 
neurological symptoms. Originally designed for multiple sclerosis patients, PR 
converts symptoms into scores and enables a comparison of the neurological state 
by the same criterion. It is easy to use, replicable and can also be applied 
retrospectively. 
The retrospective application of PR could have introduced a bias, since 
documentation of preoperative neurological symptoms may have been incomplete, 
whereas at follow-up examination all symptoms were recorded in great detail. It may 
be assumed that this bias would be able to influence the result in the sense that the 
beneficial effects of surgery may have been underestimated. However, such a bias is 
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not detectable when comparing the prospective and the retrospective groups (Table 
1).  
As a complementary measure to PR, we also applied the KPS before and after 
surgery (Figure 1) to account for the level of impairment of individuals and to 
compare the present with other recent studies.8, 16, 19-21 Increase in KPS correlated 
with a decrease in PR in the same patient (Fig. 2). Thus, both ratings concur in their 
description of the effect of surgery. This concordance validates the application of the 
Neurological Rating of Patzold also for patients with brainstem cavernoma.  
 
Patients’ subjective QoL assessment 
Focusing on patient’s neurological symptoms does not necessarily express the 
overall outcome of surgery. As an additional measure to evaluate patients’ 
assessment of QoL, we selected the SF-36 as a generic questionnaire, which is 
comprehensive, easy to use and not time-consuming. The SF-36 allows a profound 
assessment of QoL on multiple physical and psychological health concepts and 
observes patient’s responses only. As a further advantage, the SF-36 is not disease-
specific and has shown its validity and reliability in several neurological and 
neurosurgical areas 25-27. Comparison of postoperative QoL ratings of all 71 patients 
to the mean scores of the German normative population32 indicates that the patient 
group suffers from only minor QoL deficits after surgery. 
 
Effect of surgical intervention on QoL 
In a longitudinal approach, we applied SF-36 both pre- and postoperatively in 
a subgroup of 24 patients to assess the effect of surgery on patients’ QoL. The 
Mental Component Summary (MCS) improved significantly (p=0. 015) on the level of 
individual patients. From this we can conclude a beneficial effect of surgery on 
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individual patients’ QoL rating. This beneficial effect on QoL is further supported by 
our retrospective questionnaire, where 58 of 71 patients (82%) rated the effects of 
surgery as beneficial.  
 
Limitations and generalizability of the study 
When drawing conclusions from our study, the following considerations 
have to be borne in mind. (1) Patients have been carefully selected by the 
surgeon on the basis of radiological imaging and clinical considerations. 
However, the surgeon has accumulated experience over time and the selection 
criteria cannot be objectified at this stage. (2) Because brainstem cavernoma is 
a quite rare disease, all surgical procedures were kept in the hands of a single 
experienced surgeon (approximately 10 cases per year) to ensure a good 
outcome. On the one hand, this optimizes the homogeneity of the study group. 
On the other hand, multiple representative surgeons would have to be 
examined before making policy recommendations. (3) For ethical reasons we 
do not have a control group in our study. Only patients with persisting and 
disturbing clinical symptoms were advised to undergo surgery. Therefore we 
cannot assess the placebo-effect or the effect of time passing (last follow-up at 
a minimum of 6 months). To deal with this conceptual difficulty, we compared 
the postoperative QoL of all patients with the German normative population 
and found -in average- only minor QoL deficits. 
 
Comprehensive view 
All of the scales and ratings discussed above reflect specific aspects of 
patients’ lives.  For the vast majority of patients, the scales and ratings are 
complementary when describing the outcome of the surgical intervention. However, 
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in a small number of patients we observed a contradiction between objective 
neurological rating and patients’ assessment of QoL. For the 4 patients with 
neurological improvement who rated a lower QoL, we may speculate about the 
psychological pressure due to their diagnosis of a brainstem cavernoma. On the 
other hand, 6 patients with somewhat reduced neurological outcome were among the 
63 patients (88%) who experienced emotional relief after surgery. Finally, 87% of all 
patients were able to remain integrated in their preoperative professional activity.  
In a significant proportion of patients, comparison of pre- and postoperative 
scores revealed an improvement in QoL due to surgery and an emotional relief after 
total removal of the brainstem lesion. In a small number of patients, though, the 
postoperative QoL has slightly decreased. Given the sensitive location of the 
cavernoma with the risk of a potentially devastating hemorrhage, the mild degree of 
QoL reduction in a relatively low percentage of patients may be considered an 
acceptable price for obtaining elimination of a threatening vascular malformation of 
the brainstem. 
 
CONCLUSIONS 
This is the first study that applies both 1) objective scales to compare the pre- 
and postoperative state of health and, 2) subjective ratings which reflect the benefit 
from surgery in terms of QoL in a large series of patients suffering from brainstem 
cavernoma. In the vast majority of patients the objective neurological scales and 
subjective ratings were found to be complementary when describing the surgical 
outcome. However in a few individuals there was a discrepancy between objective 
and subjective ratings that underlines the importance of patients’ subjective QoL 
assessment. The results of this quite large series support the notion that 
microsurgical removal of a brainstem cavernoma represents an effective therapy in 
 15
H. Bertalanffy 
experienced hands, and is generally associated with good clinical outcome, both 
neurologically and in terms of QoL. 
 
ACKNOWLEDGEMENT 
We cordially thank Dr. Zelder, from the Institute of Neuroradiology, University 
Hospital of Marburg, for providing expert support for this demanding case series.    
 
REFERENCES 
  
1. Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U. Cerebral 
cavernomas in the adult. Review of the literature and analysis of 72 surgically 
treated patients. Neurosurg Rev. Mar 2002;25(1-2):1-53; discussion 54-55. 
2. Haque R, Kellner CP, Solomon RA. Cavernous malformations of the 
brainstem. Clin Neurosurg. 2008;55:88-96. 
3. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral 
cavernous malformations. J Neurosurg. Nov 1995;83(5):820-824. 
4. Kupersmith MJ, Kalish H, Epstein F, et al. Natural history of brainstem 
cavernous malformations. Neurosurgery. Jan 2001;48(1):47-53; discussion 
53-44. 
5. Ziyal IM, Ozgen T. Natural history of brainstem cavernous malformations. 
Neurosurgery. Oct 2001;49(4):1023-1024. 
6. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: 
natural history, diagnosis and treatment. Nat Rev Neurol. Dec 2009;5(12):659-
670. 
7. Cantu C, Murillo-Bonilla L, Arauz A, Higuera J, Padilla J, Barinagarrementeria 
F. Predictive factors for intracerebral hemorrhage in patients with cavernous 
angiomas. Neurol Res. Apr 2005;27(3):314-318. 
8. Gross BA, Batjer HH, Awad IA, Bendok BR. Brainstem cavernous 
malformations. Neurosurgery. May 2009;64(5):E805-818; discussion E818. 
9. Moriarity JL, Clatterbuck RE, Rigamonti D. The natural history of cavernous 
malformations. Neurosurg Clin N Am. Jul 1999;10(3):411-417. 
 16
H. Bertalanffy 
10. Kida Y. Radiosurgery for cavernous malformations in basal ganglia, thalamus 
and brainstem. Prog Neurol Surg. 2009;22:31-37. 
11. Tarnaris A, Fernandes RP, Kitchen ND. Does conservative management for 
brain stem cavernomas have better long-term outcome? Br J Neurosurg. Dec 
2008;22(6):748-757. 
12. Lunsford LD, Khan AA, Niranjan A, Kano H, Flickinger JC, Kondziolka D. 
Stereotactic radiosurgery for symptomatic solitary cerebral cavernous 
malformations considered high risk for resection. J Neurosurg. Feb 19 2010. 
13. Kondziolka D, Flickinger JC, Lunsford LD. Radiosurgery for cavernous 
malformations. Prog Neurol Surg. 2007;20:220-230. 
14. Fritschi JA, Reulen HJ, Spetzler RF, Zabramski JM. Cavernous malformations 
of the brain stem. A review of 139 cases. Acta Neurochir (Wien). 1994;130(1-
4):35-46. 
15. Porter RW, Detwiler PW, Spetzler RF, et al. Cavernous malformations of the 
brainstem: experience with 100 patients. J Neurosurg. Jan 1999;90(1):50-58. 
16. Hauck EF, Barnett SL, White JA, Samson D. Symptomatic brainstem 
cavernomas. Neurosurgery. Jan 2009;64(1):61-70; discussion 70-61. 
17. Chen X, Weigel D, Ganslandt O, Fahlbusch R, Buchfelder M, Nimsky C. 
Diffusion tensor-based fiber tracking and intraoperative neuronavigation for the 
resection of a brainstem cavernous angioma. Surg Neurol. Sep 
2007;68(3):285-291; discussion 291. 
18. Zausinger S, Yousry I, Brueckmann H, Schmid-Elsaesser R, Tonn JC. 
Cavernous malformations of the brainstem: three-dimensional-constructive 
interference in steady-state magnetic resonance imaging for improvement of 
surgical approach and clinical results. Neurosurgery. Feb 2006;58(2):322-330; 
discussion 322-330. 
19. de Oliveira JG, Lekovic GP, Safavi-Abbasi S, et al. Supracerebellar 
infratentorial approach to cavernous malformations of the brainstem: surgical 
variants and clinical experience with 45 patients. Neurosurgery. Feb 
2010;66(2):389-399. 
20. Ferroli P, Sinisi M, Franzini A, Giombini S, Solero CL, Broggi G. Brainstem 
cavernomas: long-term results of microsurgical resection in 52 patients. 
Neurosurgery. Jun 2005;56(6):1203-1212; discussion 1212-1204. 
 17
H. Bertalanffy 
21. Garrett M, Spetzler RF. Surgical treatment of brainstem cavernous 
malformations. Surg Neurol. Dec 2009;72 Suppl 2:S3-9; discussion S9-10. 
22. Sola RG, Pulido P, Pastor J, Ochoa M, Castedo J. Surgical treatment of 
symptomatic cavernous malformations of the brainstem. Acta Neurochir 
(Wien). 2007;149(5):463-470. 
23. Wang CC, Liu A, Zhang JT, Sun B, Zhao YL. Surgical management of brain-
stem cavernous malformations: report of 137 cases. Surg Neurol. Jun 
2003;59(6):444-454; discussion 454. 
24. Maraire JN, Awad IA. Intracranial cavernous malformations: lesion behavior 
and management strategies. Neurosurgery. Oct 1995;37(4):591-605. 
25. Brilstra EH, Rinkel GJ, van der Graaf Y, et al. Quality of life after treatment of 
unruptured intracranial aneurysms by neurosurgical clipping or by 
embolisation with coils. A prospective, observational study. Cerebrovasc Dis. 
2004;17(1):44-52. 
26. King JT, Jr., McGinnis KA, Roberts MS. Quality of life assessment with the 
medical outcomes study short form-36 among patients with cervical 
spondylotic myelopathy. Neurosurgery. Jan 2003;52(1):113-120; discussion 
121. 
27. King JT, Jr., Roberts MS. Validity and reliability of the Short Form-36 in 
cervical spondylotic myelopathy. J Neurosurg. Sep 2002;97(2 Suppl):180-185. 
28. Masur H. Skalen und Scores in der Neurologie. 2nd ed. Stuttgart: Thieme; 
2000. 
29. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-
36). I. Conceptual framework and item selection. Med Care. Jun 
1992;30(6):473-483. 
30. McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-Item Short-Form Health 
Survey (SF-36): II. Psychometric and clinical tests of validity in measuring 
physical and mental health constructs. Med Care. Mar 1993;31(3):247-263. 
31. Cenzato M, Stefini R, Ambrosi C, Giovanelli M. Post-operative remnants of 
brainstem cavernomas: incidence, risk factors and management. Acta 
Neurochir (Wien). Sep 2008;150(9):879-886; discussion 887. 
32. Bellach B, Ellert U, Radoschewski M. Der SF-36 im Bundes-
Gesundheitssurvey. Bundesgesundheitsbl -Gesundheitsforsch - 
Gesundheitsschutz. 2000;43:210-216. 
 18
H. Bertalanffy 
 19
FIGURE CAPTIONS 
Figure 1. Karnofsky Performance Status Scale (KPS) improvement. For 
the group of all patients (N=71), pre- and postoperative KPS ratings are connected 
by lines: KPS deteriorated (red), KPS unchanged (blue), KPS improved (green). For 
better visibility, lines representing individuals were offset by a small jitter. KPS 
deteriorated by 10 points in 7 patients and by 20 points in one patient. In KPS 
increased in 44 patients by up to 40 points. KPS improvement is statistically 
significant with p=0.001 (Wilcoxon signed rank test). 
 
Figure 2.  Patzold Rating (PR) change correlates with KPS change. For 
the group of all patients (N=71), the reduction in PR ratings due to surgery is 
significantly correlated with KPS improvement due to surgery ρ = -0.49 (p < 10-4). 
 
Figure 3. Quality of life (QoL) improvement, Mental Component Summary 
(MCS). For the prospective group of patients (N=24), Pre- and postoperative MCS 
ratings are connected by lines: MCS deteriorated (red), MCS change within 5 points 
(blue), MCS improved (green). MCS improvement is statistically significant with 
p=0.015 (Wilcoxon signed rank test). 
 
Figure 4. Case presentation. (A) Preoperative axial MRI, T1-weighted, Gd-
enhanced: Cavernoma visible in the brainstem (B) Preoperative fiber-tracking: Fibers 
are displaced and distorted at the level of the cavernoma (white rim). (C) 
Postoperative axial MRI, T1-weighted, Gd-enhanced: Resection cavity, no remnants 
visible. (D) Postoperative fiber-tracking: Fibers have shifted towards their natural 
position. 
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